Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hows J – The treatment of choice for young patients with an HLA identical sibling remains SCT with the intention of cure. In contrast all new patient with ASAA without a HLA identical sibling donor, those over 35–45 years of age and those with non–severe aplastic anaemia should be treated with IST as first line therapy.

Related Articles

Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
International Journal of Hematology, 10/23/09    Relevance Score: 69%

Aplastic anemia in the orient
International Journal of Hematology, 10/07/09    Relevance Score: 67%

The relationship of aplastic anemia and PNH
International Journal of Hematology, 10/07/09    Relevance Score: 67%

Immunosuppressive Therapy as Frontline Treatment for 33 Children with Acquired Severe Aplastic Anemia
Pediatric Hematology and Oncology, 10/02/09    Relevance Score: 66%

Comparative analysis of G-CSFR and GM-CSFR expressions on CD34+ cells in patients with aplastic anemia and myelodysplastic syndrome
International Journal of Laboratory Hematology, 10/28/09    Relevance Score: 65%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address